SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-17-005087
Filing Date
2017-10-18
Accepted
2017-10-18 18:01:18
Documents
1
Period of Report
2017-10-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT almenoff-form4_101617.html 4  
1 OWNERSHIP DOCUMENT almenoff-form4_101617.xml 4 3897
  Complete submission text file 0001387131-17-005087.txt   5517
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 171143318